ncl.ac.uk
IBD colorectal guidelines
People with IBD have a higher lifetime risk of colorectal cancer; updated UK guidelines give clinicians and patients evidence-based recommendations on when and how to do surveillance colonoscopy to detect precancerous changes early.
Adults with Crohn’s disease or ulcerative colitis (especially those with long-standing disease or primary sclerosing cholangitis), gastroenterologists, endoscopists, IBD nurses, and health services planners.
What To Know
The British Society of Gastroenterology has published new UK guidelines on colorectal surveillance for people with IBD (published in Gut).
The guidance—developed by clinicians, endoscopists, surgeons, nurses and patients and based on a review of >7,500 publications—includes recommendations on when to start surveillance colonoscopy (around eight years after symptom onset for most people) and on immediate colonoscopy at diagnosis for patients with primary sclerosing cholangitis.
The guidelines cover who should receive surveillance, timing and service organisation, and identify research gaps and workforce/training considerations. These recommendations aim to support personalised risk discussion between clinicians and patients and to standardise high-quality colorectal surveillance services across the NHS.
The publications include linked methodological and evidence papers (three already published, more expected), and the work highlights use of current evidence and technologies to inform clinical practice.
Read the full guideline papers in Gut for specifics about surveillance intervals, risk stratification features, recommended endoscopic modalities, and any implementation resources before making changes to care.
This is a guideline publication (Gut) summarising systematic evidence review and expert consensus. It outlines surveillance timing, risk factors and service delivery recommendations but does not itself change individual care without clinician discussion.
Review the guideline documents for detailed criteria, intervals, and caveats; some recommendations may be specific to UK NHS practice.
